| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $1.61M | $191.00K | $203.00K | $486.00K | $350.00K |
| SG&A | – | – | – | – | – |
| Operating Income | -$14.92M | -$1.58M | -$891.00K | -$1.25M | -$1.19M |
| Interest Expense | $146.00K | $213.00K | – | – | – |
| Tax Expense | $1.60K | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$15.30M | -$1.93M | -$1.22M | -$1.55M | -$1.42M |
| EPS (basic) | -0.0300 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| EPS (diluted) | -0.0300 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| Shares (diluted) | $499.68M | $404.98M | $385.56M | $361.79M | $336.04M |